☰

Valerie O. Guilpin, Ph.D. - Publications

Affiliations: 
2000 Colorado State University, Fort Collins, CO 
Area:
Pathology, Immunology
Tree Info Similar researchers PubMed Report error

2/4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Guilpin VO, Nosbisch L, Titus RG, Swardson-Olver CJ. Infection with Leishmania major stimulates haematopoiesis in susceptible BALB/c mice and suppresses haematopoiesis in resistant CBA mice. Parasitology. 126: 187-94. PMID 12666877 DOI: 10.1017/S0031182002002779  0.436
2002 Guilpin VO, Swardson-Olver C, Nosbisch L, Titus RG. Maxadilan, the vasodilator/immunomodulator from Lutzomyia longipalpis sand fly saliva, stimulates haematopoiesis in mice. Parasite Immunology. 24: 437-46. PMID 12406198 DOI: 10.1046/J.1365-3024.2002.00484.X  0.355
Low-probability matches (unlikely to be authored by this person)
2010 Gautier JC, Riefke B, Walter J, Kurth P, Mylecraine L, Guilpin V, Barlow N, Gury T, Hoffman D, Ennulat D, Schuster K, Harpur E, Pettit S. Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin. Toxicologic Pathology. 38: 943-56. PMID 20716785 DOI: 10.1177/0192623310379139  0.055
2010 Sistare FD, Dieterle F, Troth S, Holder DJ, Gerhold D, Andrews-Cleavenger D, Baer W, Betton G, Bounous D, Carl K, Collins N, Goering P, Goodsaid F, Gu YZ, Guilpin V, et al. Towards consensus practices to qualify safety biomarkers for use in early drug development. Nature Biotechnology. 28: 446-54. PMID 20458314 DOI: 10.1038/Nbt.1634  0.011
Hide low-probability matches.